Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2w14 | WR2 | Snake venom metalloproteinase BaP1 | 3.4.24 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2w14 | WR2 | Snake venom metalloproteinase BaP1 | 3.4.24 | 1.000 | |
1zxc | IH6 | Disintegrin and metalloproteinase domain-containing protein 17 | 3.4.24.86 | 0.511 | |
3hy7 | 097 | A disintegrin and metalloproteinase with thrombospondin motifs 5 | 3.4.24 | 0.506 | |
2i47 | KGY | Disintegrin and metalloproteinase domain-containing protein 17 | 3.4.24.86 | 0.496 | |
3d3w | NAP | L-xylulose reductase | 1.1.1.10 | 0.487 | |
2i47 | INN | Disintegrin and metalloproteinase domain-containing protein 17 | 3.4.24.86 | 0.480 | |
2w13 | WR2 | Snake venom metalloproteinase BaP1 | 3.4.24 | 0.474 | |
3kme | INN | Disintegrin and metalloproteinase domain-containing protein 17 | 3.4.24.86 | 0.469 | |
2a8h | 4NH | Disintegrin and metalloproteinase domain-containing protein 17 | 3.4.24.86 | 0.463 | |
3ljt | LA3 | A disintegrin and metalloproteinase with thrombospondin motifs 5 | 3.4.24 | 0.462 | |
3le9 | 727 | Disintegrin and metalloproteinase domain-containing protein 17 | 3.4.24.86 | 0.461 | |
1rx1 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
2o1s | TDP | 1-deoxy-D-xylulose-5-phosphate synthase | 2.2.1.7 | 0.460 | |
3kmc | 403 | Disintegrin and metalloproteinase domain-containing protein 17 | 3.4.24.86 | 0.459 | |
2wyv | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.457 | |
3b92 | 440 | Disintegrin and metalloproteinase domain-containing protein 17 | 3.4.24.86 | 0.456 | |
3tri | NAP | Pyrroline-5-carboxylate reductase | / | 0.456 | |
4xj4 | 3AT | Cyclic GMP-AMP synthase | / | 0.454 | |
3iah | NAP | Putative oxoacyl-(Acyl carrier protein) reductase | / | 0.453 | |
3mvq | NDP | Glutamate dehydrogenase 1, mitochondrial | 1.4.1.3 | 0.453 | |
5ecc | NAP | Dehydrofolate reductase type I | / | 0.453 | |
2b4q | NAP | Rhamnolipids biosynthesis 3-oxoacyl-[acyl-carrier-protein] reductase | 1.1.1.100 | 0.451 | |
4dbz | NDP | Putative ketoacyl reductase | 1.3.1 | 0.451 | |
2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.449 | |
1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.448 | |
3cls | FAD | Electron transfer flavoprotein subunit alpha | / | 0.448 | |
3lqs | PSZ | D-alanine aminotransferase | 2.6.1.21 | 0.446 | |
4bkq | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.446 | |
3lgp | 50X | Disintegrin and metalloproteinase domain-containing protein 17 | 3.4.24.86 | 0.445 | |
3l0v | 724 | Disintegrin and metalloproteinase domain-containing protein 17 | 3.4.24.86 | 0.444 | |
3ppo | DCK | Glycine betaine/carnitine/choline-binding protein OpuCC | / | 0.444 | |
4h4x | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.444 | |
1ju9 | NAD | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.443 | |
3w3o | ROE | Dihydroorotate dehydrogenase (fumarate) | 1.3.98.1 | 0.443 | |
1drh | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1tqf | 32P | Beta-secretase 1 | 3.4.23.46 | 0.442 | |
3te5 | NAI | 5'-AMP-activated protein kinase subunit gamma | / | 0.442 | |
3ziu | LSS | Leucyl-tRNA synthetase | / | 0.442 | |
2ieb | ZID | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.441 | |
3ivg | FG5 | Pantothenate synthetase | 6.3.2.1 | 0.441 | |
3p62 | FMN | Pentaerythritol tetranitrate reductase | / | 0.441 | |
4dfr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.440 |